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Foot-and-mouth disease (FMD) is a highly contagious viral disease which affects both domestic and wild biungulate species.
This acute disease, caused by the FMD virus (FMDV), usually includes an active replication phase in the respiratory tract for up
to 72 h postinfection, followed by hematogenous dissemination and vesicular lesions at oral and foot epithelia. The role of the
early local adaptive immunity of the host in the outcome of the infection is not well understood. Here we report the kinetics of
appearance of FMDV-specific antibody-secreting cells (ASC) in lymphoid organs along the respiratory tract and the spleen in
cattle infected by aerosol exposure. While no responses were observed for up to 3 days postinfection (dpi), all animals developed
FMDV-ASC in all the lymphoid organs studied at 4 dpi. Tracheobronchial lymph nodes were the most reactive organs at this
time, and IgMwas the predominant isotype, followed by IgG1. Numbers of FMDV-ASC were further augmented at 5 and 6 dpi,
with an increasing prevalence in upper respiratory organs. Systemic antibody responses were slightly delayed compared with the
local reaction. Also, IgMwas the dominant isotype in serum at 5 dpi, coinciding with a sharp decrease of viral RNA detection in
peripheral blood. These results indicate that following aerogenous administration, cattle develop a rapid and vigorous genuine
local antibody response throughout the respiratory tract. Time course and isotype profiles indicate the presence of an efficient T
cell-independent antibody response which drives the IgM-mediated virus clearance in cattle infected by FMDV aerosol exposure.
Foot-and-mouth disease (FMD) is a highly contagious viral dis-ease which affects a wide range of domestic and wild biungu-
late species. Although fatal cases usually occur in young animals,
the high transmissibility and morbidity observed in adult animals
infected by the FMD virus (FMDV) result in major economic
losses to the livestock industry during disease outbreaks (1). The
potentially devastating economic, social, and environmental con-
sequences of the disease have been demonstrated dramatically
during the last 2 decades by a number of different outbreaks of the
disease reported around the world (2–4).
FMDV pathogenesis presents particular features depending on
the host. Routes of entry, primary replication sites, and, conse-
quently, the associated symptoms and immune responses elicited
differ among species (reviewed in reference5). Cattle are highly
susceptible to FMDV, and the virus usually gains entry through
the respiratory tract of these animals (6). Moreover, the ability of
FMDV to replicate in tissues of the upper respiratory system, dem-
onstrated in early reports (7) and widely confirmed later using
more sensitive approaches, identified the soft palate and pharynx
as sites of FMDV replication and persistence in ruminants (8, 9).
Sutmoller and McVicar further expanded their initial findings to
include the lung as an additional portal of virus entry (10), al-
though many researchers considered the evidence for both sites of
entry to be controversial. Recently, a detailed description of the
previremic stages after experimental aerosol infection of cattle
confirmed these early results, identifying both the pharynx and
lung as primary sites for viral entry (11). Cattle infected by con-
trolled aerosol exposure of infectious FMDV (12) exhibit a pri-
mary replication event in epithelial cells of the pharynx followed
by extensive replication in pneumocytes in the lungs, which in
turn allows the establishment of a sustained viremia (11).
The detection of adaptive immune responses at the local level
after natural or experimental infection of cattle was performed in
the past through the detection of secretory immunoglobulins in
the oronasal cavities and esophageal-pharyngeal fluids (OPF), and
most of the time these efforts were focused on the discovery of
markers of infection or a carrier state (13–19). In an early report,
Figueroa et al. (13) reported neutralizing activity in samples of
saliva and nasal fluids taken from cattle infected by FMDV admin-
istered by intranasal spray. Later, McVicar and Sutmoller (18),
also using an intranasal route for infection, detected neutralizing
antibodies in saliva and OPF, suggesting a putative independence
between the local response and the antibody response detected in
serum. Other reports also showed the detection of FMDV-specific
IgM and IgA in pharyngeal fluids 1 week after infection, but they
proposed a systemic origin for these antibodies (14, 20). In these
reports, only IgA antibodies detected at late infection times were
attributed to genuine mucosal responses. None of these studies
were able to identify a local immune response earlier than the 7th
day postinfection.
Despite these studies, the role of the early host local immune
response in the outcome of the infection is not well characterized.
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In this report, we approached the study of the local immunity
against FMDV in cattle experimentally infected through the oro-
nasal route by identifying organs and tissues involved in the local
production of antibodies. Lymphoid tissues from the respiratory
system were analyzed at early times postinfection by use of an
FMDV-specific antibody-secreting cell enzyme-linked immu-
nosorbent spot (FMDV-ASC ELISPOT) assay developed for this
purpose. We provide evidence of the existence of antibody muco-
sal responses soon after infection, and we determined their origin,
time course, and immunoglobulin isotype profiles. The results
show a strong stimulation of FMDV-specific B lymphocytes to
locally produce antibodies all along the respiratory tract, includ-
ing in the tracheobronchial lymph nodes (TBL). This local re-
sponse precedes the appearance of the systemic humoral immune
response and demonstrates a close correlation with the disap-
pearance of viremia, mediated mainly by FMDV-specific IgM
antibodies.
MATERIALS AND METHODS
Experimental animals. Fifteen 15- to 18-month-old Hereford steers
weighing 300 to 350 kg each were used for the experiments. Animals were
obtained from an FMDV-free region and checked for the absence of
FMDV-specific antibodies by a liquid-phase blocking enzyme-linked im-
munosorbent assay (lpELISA) before infection. During the experimental
period, steers were kept in biosafety level 3A (BSL-3A) animal facilities
according to internal and federal regulations on biosecurity and animal
welfare (Institute of Virology, CICVyA-INTA, Argentina).
Virus, experimental infections, and clinical assessment of cattle.
Virulent FMDV strain O1 Campos was provided by the OIE FMD Refer-
ence Laboratory at SENASA, Argentina. Experimental infection through
the oronasal route was performed with a jet nebulizer attached to an
aerosol delivery system (107 50% tissue culture infective doses [TCID50]
in a 2-ml volume per animal) according to the protocols described by
Pacheco et al. (12). Cattle were monitored daily for clinical signs of FMD
after challenge. These included vesiculation, lameness, increased saliva-
tion, loss of appetite, and fever (rectal temperature of39.5°C). Clinical
scores were determined by assigning a score of 1 for fever or behavioral
modifications, 1 for lesions in the oral and nasal cavities, and 1 for each
foot that developed vesicles, with a maximum clinical score of 6.
Inactivated FMDV antigens. Inactivated suspensions of FMDV O1
Campos were kindly provided by Biogénesis-Bagó S.A. (Argentina), and
whole viral particles were purified following a standard sucrose density
gradient (SDG) centrifugation method (21) further optimized in our lab-
oratory. Briefly, inactivated FMDV suspensions were mixed 4:1 (vol/vol)
with 6%N-lauroylsarcosine (Sigma-Aldrich) in NET buffer (0.1 M NaCl-
0.004 M EDTA-0.05 M Tris, pH 8.0). This preparation was placed on a
discontinuous 15 to 45% SDG and ultracentrifuged at 45,000 g for 16 h
at 4°C in an SW-28 rotor in a Beckman Coulter ultracentrifuge. Fractions
were collected by selecting the peak absorbance at 260 nm and were
pooled. This preparation was further centrifuged at 100,000 g for 16 h at
4°C, and pelleted virus was resuspended in NET buffer, quantified by
spectrophotometry at 260 nm, and stored at80°C. The integrity of 140S
particles was assessed by SDG and a monoclonal antibody (MAb)-based
indirect ELISA applied to each gradient fraction, as described previously
(22).
Serumand tissue sample collection. Serum samples were collected on
a daily basis from the arrival of the animals until the time of necropsy. One
steer (C135) was euthanized and necropsied for tissue collection prior to
the experimental infections to provide negative-control samples for im-
munological assays. The rest of the animals were aerosol inoculated and
then euthanized and necropsied at different time points from 2 to 6 days
postinfection (dpi), except for two steers that were kept until 14 dpi and
were sampled daily only for serum. Tissue collection was based on previ-
ous reports showing the main sites of FMDV replication along the respi-
ratory tract (11, 23, 24). Samples obtained postmortem included 6 ana-
tomically distinct organs and tissues: mandibular lymph nodes (ML),
medial and lateral retropharyngeal lymph nodes (MRL and LRL, respec-
tively), pharyngeal tonsils (PhT), tracheobronchial lymph nodes (TBL),
and the spleen. Tissues were collected aseptically and placed in ice-cold
wash buffer (RPMI 1640, 10 mM HEPES, 106 units/ml penicillin G so-
dium, 700 mg/ml streptomycin, and 500 mg/ml gentamicin) until pro-
cessing.
Isolation of mononuclear cells from lymphoid tissues. All tissues
were processed to obtain mononuclear cell suspensions according to pre-
viously published protocols (25), with minor modifications. Briefly, tis-
sues were first ground in cell collectors with 80-mesh screens (Sigma-
Aldrich, St. Louis, MO) to obtain single-cell suspensions. Cells were then
pelleted, resuspended in 90% Percoll solution (GE Healthcare, Uppsala,
Sweden), and centrifuged at 5,000  g (30 min at 4°C). Cell pellets were
resuspended in 43% Percoll solution, transferred to a 70% Percoll solu-
tion, and centrifuged at 4,000 g (30 min at 4°C). Mononuclear cells were
collected at the 43 to 70% interface and resuspended in complete medium
(wash buffer with 10% fetal bovine serum), and their viability was deter-
mined by trypan blue exclusion.
ELISPOT assay for FMDV-specific ASC. An FMDV-ASC ELISPOT
assay was developed for this study. Ninety-six-well nitrocellulose plates
(Millipore, MA) were coated overnight with inactivated purified FMDV
O1 Campos and blocked with 4% skim milk for 1 h at room temperature
(RT). Mononuclear cells were seeded in FMDV-coated plates in 2-fold
dilutions (5  106 and 2.5  106 cells per ml) in triplicate wells and
incubated overnight at 37°C with 5% CO2. After 5 washes with phosphate-
buffered saline (PBS), mouse anti-bovine IgG1 or IgG2 monoclonal
antibodies (BD-Serotec, Oxford, United Kingdom) were added (1:500
dilution) and incubated for 1 h at RT. Reactions were revealed with anti-
mouse IgG horseradish peroxidase (HRP)-labeled conjugate (KPL,
United Kingdom) for 1 h at RT, followed by addition of True Blue perox-
idase substrate (KPL, United Kingdom). IgM and IgA ASC were detected
with HRP-labeled sheep anti-bovine IgM and IgA sera (Bethyl, TX), di-
luted 1:5,000 and revealed as described above. Spots corresponding to
ASC were visualized and counted manually under a stereomicroscope.
Spots from control wells were subtracted from experimental wells, and
results were expressed, unless otherwise indicated, as the mean number of
ASC per 5 105 cells for triplicate wells.
FMDVRNAdetection in serum samples. Specific sense and antisense
primers were utilized to amplify a 259-nucleotide fragment of the viral
polymerase gene (positions 7079 to 7338). Viral RNA was extracted from
serum samples (140 l) by use of a QIAamp viral RNA minikit (Qiagen),
and reverse transcription was carried out using the antisense primer and
reverse transcriptase (from Moloney murine leukemia virus [M-MLV];
Promega) under standard conditions. The resulting template cDNAs or
10-fold dilutions of a standard plasmid containing the 3D gene were used
for PCRs, which were performed with a real-time PCR master mix
(Mezcla Real; Biodynamics) and ROX reference dye (Invitrogen). The
reaction was started with a 10-min incubation at 95°C, followed by 45
amplification cycles (95°C for 15 s followed by 1 min at 60°C), and after
cycling, a dissociation stage was carried out to detect specific amplifica-
tion. A standard curve built using plasmid dilutions with the specific
primers was utilized to correlate threshold cycle (CT) values obtained
from serum samples with the number of FMDV genome copies per ml.
The standard curve presented a slope of 3.332 (primer efficiency,
99%) and an R2 value of 0.993. Samples and standards were run in
triplicate in an ABI 7500 thermocycler (Applied Biosystems) and analyzed
using model 7500 SDS software v 1.3.1. Both primers and the standard
plasmid were kindly provided by Guido König.
IgM purification from serum samples. Total IgM was purified from
pooled serum samples by affinity chromatography in an Äkta Explorer
system (GE Healthcare). Serum samples were diluted 1:3 in binding buffer
[20 mM sodium phosphate, 0.8 M (NH4)2SO4, pH 7.5] and applied to
HiTrap IgM HP purification columns (GE Healthcare). Unbound input
Pega et al.
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sample was collected and preserved as the IgM-depleted fraction, and
IgM-purified fractions were eluted in 20 mM sodium phosphate buffer,
pH 7.5. A purified commercial bovine IgM standard (Sigma) was also
included as a control for the whole purification procedure. The IgM con-
tent in all fractions was confirmed by 10% SDS-PAGE and Western blot
assay, using an HRP-labeled sheep anti-bovine IgM (Bethyl) as a probe
(data not shown). All fractions assayed for virus-neutralizing activity were
further adjusted to match a 1:8 dilution of the original whole-serum pools.
Serology determinations. FMDV-specific total antibody titers were
determined by an lpELISA originally developed by Hamblin et al. (26) and
further modified by Periolo et al. (27).
Neutralizing antibodies were detected by a microplate virus neutral-
ization assay modified in our laboratory (28). Briefly, serum samples (50
l; 1:16 dilution in RPMI) were added to 96-well cell culture plates and
incubated at 37°C for 1 h with four 10-fold dilutions of infective FMDV
O1 Campos (50l; 1 to 1,000 TCID50). BHK-21 cell suspensions (100l;
3 105 cells/ml) were then added and incubated for 72 h at 37°C with 5%
CO2. Virus dilutions were prepared from a 10
8-TCID50 FMDV O1 Cam-
pos stock suspension, and the concentration was assessed for each test,
allowing a variation of0.5 log10 from the expected value. Neutralization
assays performed for purified IgM and pooled sera were carried out es-
sentially in the same way, except that samples were diluted 1:8 (50 l),
mixed with the different virus dilutions (50 l), and applied to BHK-21
cell monolayers already seeded in 96-well cell culture plates. For both
assays, neutralizing antibody titers were expressed as the TCID50 neutral-
ized by the diluted samples, according to the method of Reed and Muench
(29).
FMDV-specific isotype ELISA was performed as reported by Capozzo
et al. (30), except that sheep anti-bovine IgG1 and IgG2 HRP-conjugated
antibodies were used at a dilution of 1:750, and sheep anti-bovine IgM
HRP-conjugated antibody was used at 1:5,000 (BD-Serotec, Oxford,
United Kingdom).
Statistical analysis. Differences in the number of ASC produced per
isotype per animal and between FMDV-specific serum IgM titers at dif-
ferent times were analyzed by one-way analysis of variance (ANOVA),
and pairwise comparisons were carried out using the Tukey test. Differ-
ences in mean FMDV-specific serum isotype titers at different times were
analyzed by two-way ANOVA following the Bonferroni method. Analyses
were performed using Graph Pad Prism 5.0 software (Graph Pad Software
Inc.).
RESULTS
Progression of viremia and clinical symptoms following exper-
imental oronasal FMDV infection in cattle. A total of 12 animals
were experimentally infected by the oronasal route following the
procedure described by Pacheco et al. (12). Clinical symptoms
were similar across the infected cattle. Animals started exhibiting
fever and general lameness between 1 and 2 days after exposure,
and the first vesicles were observed from day 2 postinfection. As
expected, clinical scores progressed in a time-dependent manner,
up to the maximum score of 6, corresponding to a generalized
infection with lesions in all feet and in oral and nasal cavities at 6
dpi (data not shown). FMDV RNA was detected in serum after 24
h postinfection; the number of viral genome copies sharply in-
creased to a peak at 3 dpi and disappeared from the bloodstream of
infected animals by 5 dpi, coinciding with the onset of systemic
antibody responses (Fig. 1A).
Systemic adaptive antibody responses in FMDV-infected
cattle. Circulating FMDV-neutralizing antibodies were initially
detected at 4 dpi in 2 of 8 assayed animals, and they were observed
in all animals (n  5) at 5 dpi (Fig. 1A). Similar results were
observed when total FMDV-reacting antibodies were studied by
lpELISA (data not shown). Isotype profiles at 4 dpi showed that
mean FMDV-specific IgM titers were at similarly low levels as
IgG1 antibodies, while IgG2 was barely evident. Mean FMDV-
specific IgM titers, however, increased significantly at 5 dpi (P
0.05) and were significantly higher than IgG1 or IgG2 titers at 5
dpi (P  0.05). FMDV-specific IgG1 and IgG2 levels remained
unchanged between 4 and 6 dpi. Following this initial phase, IgG1
levels dramatically increased, peaking at 9 dpi and remaining sta-
ble between 11 and 14 dpi, the last sampling time point. IgM titers
remained mostly unchanged from 5 dpi, showing little fluctuation
between 12 and 14 dpi, and IgG2 titers remained low throughout
the study period (Fig. 1B).
Mucosal adaptive antibody responses inFMDV-infected cat-
tle. Animals were sacrificed at 2 (n  1), 3 (n  3), 4 (n  3), 5
(n  2), or 6 (n  3) dpi to study FMDV-specific mucosal im-
FIG1 Time course of viral RNA detection and systemic adaptive immune responses in cattle after FMDV aerosol exposure. (A) Viral RNA detection in sera from
infected cattle at each time point is indicated as the mean number of FMDV genome copies/ml  standard deviation (SD) (right axis). Systemic antibody
responses are represented by the number of serum neutralizing doses detected for each animal, and results are expressed as the mean TCID50 neutralized by the
diluted sera from all surviving animals at each time SD (left axis). (B) Isotypes of FMDV-specific serum antibodies were analyzed by an FMDV-specific isotype
indirect ELISA. Each line corresponds to a particular isotype, and each point represents the average ELISA titer obtained for all animals assayed. Titers are
expressed as the highest dilution of serum reaching an optical density of 0.2 (mean value for 25 negative sera plus 2 SD). *, significant differences between IgM
titers at 4 and 5 dpi (P 0.05); **, significant differences between IgM and IgG1 titers at 5 dpi (P 0.05).
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mune responses along the respiratory tract by FMDV-ASC
ELISPOT assay. An additional naïve animal (C135) was also sac-
rificed and processed for use as a negative control. Onset of local
responses was established between 3 and 4 days postinfection.
While FMDV-specific ASC were not detected in any of the indi-
viduals studied at 3 (n 3) or 2 (n 1) dpi, all animals analyzed
at 4 dpi (n  3) developed adaptive responses in most of the
lymphoid tissues sampled. The mean number of FMDV-specific
ASC (per 5 105 total mononuclear cells) detected in the organs
of the respiratory tract, considering all animals and organs analyzed
at each time, rose 7-fold between 4 (mean  standard deviation
[SD], 166.4 104.0) and 5 (mean SD, 1,172.5 726.2) dpi and
3.4-fold between 5 and 6 dpi (mean  SD, 4,011.0  1,003.9)
(see Table S1 in the supplemental material). A strong FMDV-
specific antibody response was detected in all infected cattle at 6
dpi: FMDV-ASC represented up to 0.39% of the total mononu-
clear cells extracted from mandibular lymph nodes and 0.23% of
those from the tracheobronchial lymph nodes (Fig. 2; see Table S1
in the supplemental material). When ELISPOT assay results were
considered in terms of the total number of FMDV-specific ASC
per organ, no major changes in the general profile were observed,
with the exception of values corresponding to the largest organ,
the spleen, and the smallest one, the pharyngeal tonsil.
Lymphoid organs involved in local production of FMDVan-
tibodies in infected cattle. Five different lymphoid tissues from
the lower and upper respiratory systems were sampled: mandibu-
lar and retropharyngeal (lateral and medial) lymph nodes, pha-
ryngeal tonsil, and TBL. The spleen was also analyzed as a repre-
sentative measurement of systemic responses elicited in each
animal. TBL were the most reactive organs in all the individuals
studied 4 days after FMDV infection (Fig. 2). The spleen (S), me-
dial retropharyngeal (MRL), and mandibular (ML) lymph nodes
followed the TBL in the mean number of anti-FMDV ASC, al-
though no differences were registered among these organs com-
pared with the lateral retropharyngeal lymph nodes (LRL) or the
pharyngeal tonsils (PhT), which presented only a marginal reac-
tivity.
A similar profile was found at 5 dpi, with TBL as the predom-
inant organ for FMDV-specific ASC, followed by MRL (steer
C118) or ML (steer C146). Differences in FMDV-specific ASC
numbers in MRL and ML were small with respect to those in TBL
and LRL; PhT had increased anti-FMDV ASC numbers relative to
those in TBL. ASC numbers in the spleen were augmented in one
of the animals (steer C118), without exhibiting significant differ-
ences within the other organs. The remaining steer did not display
a further increase in spleen stimulation relative to the value from 4
dpi (Fig. 2; see Table S1 in the supplemental material).
The increasing relevance of the upper respiratory organs in the
mucosal response initiated at 5 dpi was confirmed at 6 dpi. ML
were significantly the most reactive organs in all animals studied at
this time (n  3), followed by the TBL and MRL, with similar
values for all animals analyzed. The number of FMDV-ASC in ML
from the 3 steers increased 9-fold, on average, relative to the
number from the previous day, while the LRL, which displayed
relatively low levels at 4 and 5 dpi, also increased their average
number 7-fold. Rises registered in the PhT were moderate,
reaching an average of 128 FMDV-specific ASC/5  105 mono-
nuclear cells. Responses in the spleen were modestly higher than
those of the previous day for two of the animals (steers C115 and
C126), although the third animal analyzed (steer B995) presented
a marked increase in the anti-FMDV reactivity in this organ as
measured by ELISPOT assay, reaching a total of 1,220 ASC/5 
105 mononuclear cells (see Table S1 in the supplemental mate-
rial).
Immunoglobulin isotype profiles induced by local adaptive
immunity in FMDV-infected cattle. As mentioned above, TBL
were the most stimulated organs in all three animals 4 days after
infection, with IgM as the dominant isotype among the FMDV-
ASC developed in these organs. IgG1 was consistently second with
regard to detection levels, with levels 3- to 4-fold lower than those
for IgM. IgA and IgG2 ASC were detected at very low levels or were
undetectable. This pattern was repeated overall, with lower mag-
nitudes, in all the local organs assayed. FMDV-specific ASC in the
spleen also exhibited increased levels of IgM-producing cells com-
pared to cells expressing the rest of the isotypes. Splenic IgG2 ASC
were not detectable at this time, and IgA and IgG1 values, which
were 8 to 10 times lower than the IgM value, showed no significant
differences between them (Fig. 3; see Table S1 in the supplemental
material).
Five days after infection, TBL were still the most stimulated
organs in both animals studied. The isotype pattern observed was
similar to that of the previous day, although the IgM/IgG1 and
IgM/IgA ratios increased 3- to 4-fold. The total number of FMDV-
specific ASC in TBL was also augmented 5-fold relative to that on
the previous day, and thus an important fraction of this increase
was due to the IgM ASC. The same figure was registered in the
FIG 2 Detection of FMDV-specific antibody-secreting cells in lymphoid organs of the respiratory tract of infected cattle. After oronasal infections, FMDV-
specific ASC were detected by an FMDV-ASC ELISPOT assay. Mandibular lymph nodes (ML), pharyngeal tonsils (PhT), lateral (LRL) and medial (MRL)
retropharyngeal lymph nodes, tracheobronchial lymph nodes (TBL), and the spleen (S) were processed and assayed by the FMDV-ASC ELISPOT assay. Results
are expressed as either the number of FMDV-specific ASC per 5 105 extracted mononuclear cells (A) or the total number of FMDV-specific ASC per organ (B).
Each bar corresponds to the average value for 3 individuals (except for 5 dpi, where n 2) plus SD for each particular organ.
Pega et al.
2492 jvi.asm.org Journal of Virology
 
 
spleen, since IgG1 and IgA isotypes showed little differences from
the previous day, while mean IgM ASC numbers went from 21 to
118 ASC per 5  105 extracted cells (Fig. 3). IgM was also the
dominant isotype in the FMDV-ASC detected in the rest of the
organs tested, and differences with the other isotypes remained
mostly constant.
The general isotype pattern at 6 dpi was still dominated by IgM
ASC for all animals and organs assayed, although a relative rise in
the numbers of FMDV-specific IgG1 and IgA ASC was observed,
mainly in the ML, TBL, and spleen (Fig. 3). The number of
FMDV-specific IgG2 ASC was also augmented, particularly in
ML, reaching IgA levels. One of the animals (steer B995) devel-
oped a large number of FMDV-specific IgG1 ASC (789 ASC/5
105 cells), close to the IgM level in the same animal and organ
(1,003 ASC/5  105 cells). Interestingly, this was the same indi-
vidual that also presented a significantly larger number of anti-
FMDV splenic ASC than the other 2 animals studied at that time
(see Table S1 in the supplemental material).
Neutralizing activity of FMDV-specific serum IgM antibod-
ies isolated from infected cattle. In order to evaluate the contri-
butions of the different isotypes to the phenomenon of virus neu-
tralization during infection in cattle, the neutralizing ability of
purified serum IgM was tested using a pool of sera obtained daily
from 4 to 6 days after infection. For each time point, serum IgM
was affinity purified and its neutralizing activity compared to
those of whole pooled sera, IgM-depleted serum fractions, and
pooled sera from uninfected animals. As shown in Fig. 4, neutral-
izing activity of the tested samples was clearly detected after 4 dpi,
and the serum IgM fractions from 5 and 6 dpi neutralized infective
FMDV to levels similar to those with whole serum. In contrast, the
neutralizing capacity of the IgM-depleted serum fractions resem-
bled that of the normal serum for all time points. This result is in
line with a central role of this immunoglobulin subclass in the
early clearance of viremia in infected animals.
DISCUSSION
The detection of specific neutralizing antibodies in oronasal and
esophageal-pharyngeal fluids has previously been described for
cattle infected by oronasal routes with different FMDV O1 strains
(13, 15, 18). All of these reports were based on results obtained
starting at least 1 week after the experimental infections. Conse-
quently, they did not clearly determine the onset of the local anti-
FMDV antibody response in naturally infected cattle or indubita-
bly identify the exact organ/tissue originating that response.
Neutralizing activity in cattle infected by nasal spray exposure
was reported for nasal fluids and saliva 10 and 21 days after nasal
spray infection, respectively (13), and around 2 weeks after instil-
lation for OPF samples (18). An even earlier report by Kaaden and
Matthaeus (16) revealed a poor correlation between serum and
saliva neutralization titers, with IgA as the predominant isotype in
salivary secretions. McVicar and Sutmoller (18) also compared
the kinetics of the serum and mucosal antibody responses up to 30
weeks after primary infection and concluded that the lack of tem-
poral correlation between them might reflect the independence of
the FMDV-neutralizing activity at systemic and local levels. This
perspective, however, was later set aside by other authors. Francis
et al. (14) detected FMDV-specific IgM and IgA antibodies in
pharyngeal fluid in naïve cattle 7 days after virus exposure but
proposed that these were actually due to serum and tissue fluid
escaping from the damaged mucosa during the acute inflamma-
tory phase of infection. According to these authors, active local
antibody production was evident only at later stages (20 to 60 days
after virus exposure) and corresponded to the rise in specific IgA
antibodies. Archetti et al. also followed the kinetics of serum and
OPF antibodies in naïve cattle by use of ELISA (20). Even when the
earliest positive reaction was detected at day 14 postinfection, they
proposed that only the IgA responses peaking after healing of the
vesicular lesions (between 4 and 8 weeks postinfection) were pro-
duced by mucosa-resident antibody-secreting B lymphocytes.
FIG 3 Isotype profiles of the FMDV-ASC developed in cattle after FMDV aerosol exposure. Mononuclear cells were purified from mandibular lymph nodes
(ML), pharyngeal tonsils (PhT), lateral (LRL) and medial (MRL) retropharyngeal lymph nodes, tracheobronchial lymph nodes (TBL), and the spleen (S) and
assayed by the FMDV-ASC ELISPOT assay, using monoclonal (IgG1 and IgG2) or polyclonal (IgM and IgA) antibodies against bovine immunoglobulin isotypes
as probes. Results are expressed as the number of FMDV-specific ASC per 5 105 extracted cells, and each bar corresponds to the average value for 3 individuals
(except for 5 dpi, where n 2) plus SD for each particular isotype and organ.
FIG 4 Virus-neutralizing activity in whole sera and antibody fractions. IgM
antibodies were purified from pooled serum samples taken between 4 and 6
dpi. Neutralizing antibodies were determined for sera from nonimmune cat-
tle, as well as pooled sera, IgM, and IgM-depleted fractions from infected
animals, as described in Materials and Methods. Results are expressed as
TCID50 neutralized by the different diluted samples.
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Therefore, the role of the early host local immune response in the
outcome of the infection is still not well understood.
We approached the study of the mucosal humoral responses
induced by FMDV infection by the aerosol route in cattle by ana-
lyzing the induction of ASC specific for the virus in lymphoid
tissues located along the respiratory tract to obtain information
about the source of the antibodies detected at local lymphoid or-
gans in relation to tissues involved in the initial viral replication
stages (11, 23, 24).
Interestingly, patterns of immune reactivity found in lym-
phoid organs after infection were associated with the early stages
of replication of aerosolized FMDV. Arzt et al. (11) used the same
aerosol exposure method to show that after primary replication
(during 6 h postexposure) in the follicle-associated epithelium
overlying the pharyngeal mucosa-associated lymphoid tissue, the
virus followed an extensive replication in pneumocytes between
24 and 48 h postexposure. They proposed that this replication in
the lungs allows the virus to establish and sustain viremia. Accord-
ingly, our results demonstrated that the onset of local adaptive
responses at 4 dpi was dominated by the TBL, with poor stimula-
tion of the lymph nodes from the upper respiratory system, and
that only at 6 dpi were lymph nodes from the upper tract able to
exceed TBL ASC counts.
It is possible to hypothesize that this first extensive replication
of FMDV in large organs such as the bovine lungs is directly re-
lated to the predominant stimulation of the tracheobronchial
lymph nodes draining these tissues observed on days 4 and 5 after
infection and thus independent from the humoral systemic re-
sponse. It is probable that primary replication in nasopharynx and
larynx tissues produced only limited amounts of FMDV, and
therefore only a modest number of FMDV-specific B cells were
activated in lymph nodes from the upper tract at the onset of the
response. Only when the virus was extended in a generalized in-
fection through the peripheral circulation could a larger number
of FMDV-specific B lymphocytes be activated in these lymph
nodes. Progression of the response from 6 dpi led to a more ex-
tended immunoglobulin class switching and to an increasing im-
portance of the systemic immunity, as reflected by the spleen ASC
responses and IgG1 serum levels detected between 7 and 14 dpi.
Interestingly, IgM mediated most of the local ASC responses co-
existing with the end of the viremia phase at 5 dpi.
The FMDV capsid possesses key structural features compatible
with type 2 T cell-independent antigens, which are able to stimu-
late antibody production in the absence of major histocompati-
bility complex (MHC) class II-restricted T cell help (31). In addi-
tion, as demonstrated for poliovirus (32) and vesicular stomatitis
virus (33), the high local antigen concentrations reached during
infection, which allow replicating virus to be present at high levels
for a prolonged time, represent a key factor in the efficient induc-
tion of T cell-independent responses (34). An early work from our
laboratory demonstrated that FMDV-specific primary and short-
term memory protective antibody responses were not dependent
on the CD4	 T-helper cells in a mouse model (35). Only recently,
Juleff et al. extended these results to cattle, showing that a rapid
and class-switched antibody response could be elicited by FMDV
infection in bovines transiently depleted of CD4	T cells (36). Our
results at local and systemic levels are consistent with these previ-
ous findings, even when differences can be pointed out regarding
this later work. Juleff et al. first detected FMDV-specific serum
IgG1 antibodies at 5 dpi, with FMDV-specific IgM antibodies
identified 1 day later. In our work, FMDV-specific IgM responses
were rapidly induced at the local level 4 days after infection, and
IgG1 ASC numbers were comparable to those of the IgM-secret-
ing cells only at 6 dpi. Serum responses followed a similar kinetics;
while specific IgM and IgG1 antibodies were detected between 4
and 5 dpi, IgM titers peaked at 5 dpi, exhibiting significantly
higher titers than the other isotypes at that time.
A previous report by Abu Elzein and Crowther indicated that
FMDV-neutralizing activity in infected cattle started between 4
and 5 dpi, showing a biphasic development with a slow initial rise
until 10 dpi, when a sharp increase in titer was observed (37).
These authors found that both FMDV-specific IgM and IgA were
present from 4 dpi, but since IgG1 and IgG2 were also detected in
smaller amounts, they could not attribute the neutralizing activity
to a determined isotype. We showed here that anti-FMDV IgM
predominated in the adaptive response at both the local and sys-
temic levels, and interestingly, the peak of anti-FMDV IgM in
serum closely correlated with a sharp decrease in viral RNA detec-
tion in blood at 5 dpi. Supporting the role of IgM as a critical
element in controlling/clearing FMDV infection in cattle, we
demonstrated here that a considerably large proportion of the
neutralizing activity of sera sampled 5 and 6 days after infection
was due to the FMDV-specific IgM antibodies.
Altogether, our observations suggest that the development of
local adaptive responses coincides with tissues where the virus
undergoes significant productive replication and that IgM anti-
bodies are the main effectors mediating FMDV clearance from
peripheral circulation and thus represent a key factor in the devel-
opment of early protective responses.
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Table S1. Number of FMDV-specific ASC in all animals and organs assayed from 4 to 6 
days post-infection.  
  
C181 / 4 dpi * C165 / 4 dpi C182 / 4 dpi C118 / 5 dpi 
Isotype Organ mean±SD # 
Significant 
Differences §  mean±SD 
Significant 
Differences mean±SD 
Significant 
Differences  mean±SD 
Significant 
Differences 
IgM 
ML 14.0±1.9 TBL 8.0±6.2 TBL 5.6±1.8 TBL 43.8± 8.1 TBL 
MRL 12.0±11.4 TBL 2.3±0.6 TBL 7.0±1.7 TBL 130.7±28.9 TBL 
LRL 5.0±3.8 TBL 3.3±2.0 TBL 2.0±1.0 TBL 24.3±5.1 TBL 
PhT 7.5±3.9 TBL 1.3±0.6 TBL 3.0±1.4 TBL 21.7±14.0 TBL 
TBL 53.5±21.4 all 41.7±11.4 all 180.8±79.2 all 328.3±84.3 all 
S 7.0± 2.0 TBL 4.0±1.7 TBL 21.6±18.0 TBL 74.5±52.2 TBL 
IgG1 
ML 2.5±0.8 TBL 1.8±1.0 TBL 0.5±0.8 TBL 33.3±13.0 MRL,LRL,TBL,S 
MRL 1.0±1.0 TBL 1.3±0.6 TBL 7.7±4.5 TBL 71.3±16.2 all 
LRL 1.0±1.0 TBL 0.0±0.0 TBL 1.0±1.0 TBL 0.0±0.0 ML,MRL,PhT,TBL 
PhT 0.0±0.0 TBL 1.0±1.0 TBL 3.7±1.5 TBL 26.0±5.3 MRL,LRL,TBL,S 
TBL 23.8±10.7 all 10.2±2.2 all 42.3±9.6 all 98.7±6.1 all 
S 2.3±1.5 TBL 0.7±1.1 TBL 3.3±3.0 TBL 0.3±0.6 ML,MRL,PhT,TBL 
IgG2 
ML 0.0±0.0 TBL 0.3±0.8 none 0.7±1.1 TBL 6.7±3.0 MRL,TBL 
MRL 2.7±1.1 TBL 0.0±0.0 none 1.0±1.0 TBL 19.3±4.2 ML,MRL,S 
LRL 0.7±0.8 TBL 0.0±0.0 none 0.3±0.6 TBL 3.3±2.3 MRL,TBL 
PhT 0.0±0.0 TBL 1.3±1.5 none 2.3±0.6 none 7.3±4.2 TBL 
TBL 6.3±2.6 all 1.3±2.8 none 5.3±3.2 all 29.3±8.3 ML,LRL,PhT,S 
S 1.0±1.7 TBL 2.7±3.5 none 1.3±1.1 none 0.0±0.0 MRL,TBL 
IgA 
ML 0.7±1.1 none 3.3±2.5 MRL,LRL,TBL,S 1.0±1.7 TBL 20.5±7.5 MRL,LRL,PhT,S 
MRL 0.0±0.0 none 0.0±0.0 ML 5.3±2.5 TBL 11.0±5.3 all 
LRL 0.0±0.0 none 0.0±0.0 ML 0.7±0.6 TBL 2.7±2.0 ML,MRL,TBL 
PhT 1.3±1.5 none 1.7±0.6 none 0.0±0.0 TBL 2.8±2.0 ML,MRL,TBL 
TBL 2.7±3.8 none 0.0±0.0 ML 23.7±7.0 all 22.5±4.0 MRL,LRL,PhT,S 
S 5.3±3.0 none 0.0±0.0 ML 1.0±1.7 TBL 0.0±0.0 ML,MRL,TBL 
 
* steer number/days post-infection, # mean ASC number/5x105 mononuclear cells ± standard 
deviation, § significant differences with other organs for this isotype and steer (p<0.05) 
 
  
Table S1 (cont.). Number of FMDV-specific ASC in all animals and organs assayed from 4 
to 6 days post-infection.  
  
C146 / 5 dpi C115 / 6 dpi C126 / 6 dpi B995 / 6 dpi 
Isotype Organ 
mean±SD 
# 
Significant 
Differences §  mean±SD 
Significant 
Differences mean±SD 
Significant 
Differences  mean±SD 
Significant 
Differences 
IgM 
ML 58.0±5.6 all 1,099.0±23.0 all 774.7±6.4 all 1,003.0±8.0 all 
MRL 34.3±4.9 ML,LRL,TBL,S 26.3±11.0 all 485.3±5.0 all 918.7±16.2 ML,LRL,PhT,S 
LRL 16.0±5.5 ML,MRL,TBL 698.7±26.2 all 313.3±3.0 all 218.0±30.8 all 
PhT 26.0±2.0 ML,TBL,S 397.3±10.1 all 139.3±5.1 all 56.7±3.0 all 
TBL 124.0±12.1 all 881.0±21.4 all 468.0±5.6 all 897.3±17.5 ML,LRL,PhT,S 
S 5.6±2.2 ML,MRL,PhT,TBL 198.0±21.1 all 165.0±7.5 all 1,101.0±20.6 all 
IgG1 
ML 14.7±5.3 MRL,S 200.0±7.2 LRL,PhT,S 162.3±3.2 all 789.3±10.3 all 
MRL 21.8±5.3 LRL,S 167.3±29.7 LRL,PhT,S 46.7±7.2 all 273.3±7.0 all 
LRL 2.1±1.8 ML,MRL,PhT,TBL 54.7±8.3 ML,MRL,TBL,S 26.7±2.0 ML,MRL,TBL 56.0±15.9 ML,LRL,TBL 
PhT 17.3±3.0 LRL,S 19.3±2.9 ML,MRL,TBL 23.3±2.0 ML,MRL,TBL 6.5±4.5 ML,MRL,TBL,S 
TBL 19.0±6.7 LRL,S 180.7±21.9 LRL,PhT,S 106.3±9.7 all 194.5±49.6 all 
S 4.5±2.6 ML,MRL,PhT,TBL 16.7±6.0 ML,MRL,LRL,TBL 24.7±5.0 ML,MRL,TBL 104.7±21.6 ML,MRL,PhT,TBL 
IgG2 
ML 11.3±3.0 MRL,LRL,S 168.7±21.9 all 101.0±5.6 all 64.3±71.0 LRL,PhT,S 
MRL 4.7±2.9 ML 94.0±30.8 ML,LRL,PhT,S 16.7±4.2 ML,TBL 19.3±8.7 none 
LRL 2.7±0.6 ML 17.0±15.6 ML,MRL,TBL 15.0±2.6 ML,TBL 5.2±2.4 ML 
PhT 7.3±1.1 none 9.0±1.0 ML,MRL,TBL 12.0±3.0 ML,TBL 1.0±0.9 ML 
TBL 7.0±4.0 none 62.0±9.9 ML,LRL,PhT,S 34.3±3.0 all 40.7±15.5 none 
S 2.0±1.0 ML 9.5±3.8 ML,MRL,TBL 10.3±1.5 ML,TBL 4.2±3.6 ML 
IgA 
ML 8.5±3.2 MRL,LRL,S 146.0±16.4 all 70.3±15.9 all 40.7±7.8 MRL,LRL,PhT,S 
MRL 1.3±1.5 ML 88.7±15.1 all 12.0±6.5 ML 23.7±8.3 ML,LRL,PhT 
LRL 1.3±1.1 ML 8.7±1.5 ML,MRL,TBL 23.3±2.0 ML 3.5±4.6 ML,MRL,TBL 
PhT 5.2±3.1 none 6.5±2.3 ML,MRL,TBL 18.7±0.6 ML 7.5±9.0 ML,MRL,TBL 
TBL 5.7±1.5 none 52.7±3.0 all 18.7±0.6 ML 33.4±11.7 LRL,PhT,S 
S 1.3±2.3 ML 7.7±2.0 ML,MRL,TBL 3.3±4.2 ML 11.5±6.0 ML,TBL 
 
* steer number/days post-infection, # mean ASC number/5x105 mononuclear cells ± standard 
deviation, § significant differences with other organs for this isotype and steer (p<0.05) 
 
